Edwards Lifesciences Corp (EW)

NYSE
Currency in USD
Disclaimer
68.13
-0.13(-0.19%)
Closed
After Hours
68.80+0.67(+0.98%)
EW Scorecard
Full Analysis
Management has been aggressively buying back shares
Earnings results expected in 10 days
Fair Value
Day's Range
67.9669.64
52 wk Range
58.9396.12
Prev. Close
68.26
Open
68.44
Day's Range
67.96-69.64
52 wk Range
58.93-96.12
Volume
4,185,884
Average Volume (3m)
6,934,030
1-Year Change
-3.74%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
EW Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
76.50
Upside
+12.29%
Members' Sentiments
Bearish
Bullish
ProTips
4 analysts have revised their earnings downwards for the upcoming period
Show more

InvestingPro Research for Edwards Lifesciences Corp


TAVR Challenges
Explore Edwards Lifesciences' strategies to navigate slowing growth in its core TAVR business amid hospital workflow issues and increased competition
TMTT Growth Potential
Delve into the company's thriving Transcatheter Mitral and Tricuspid Therapies segment, poised to become a significant revenue drive
Strategic Acquisitions
Learn how recent $1.1 billion acquisitions of JenaValve and Endotronix could pave the way for Edwards Lifesciences' return to double-digit growth
Financial Outlook
Analysts project EPS of $2.53-$2.60 for FY2025, with price targets ranging from $60 to $90, reflecting varied views on the company's growth prospects

Edwards Lifesciences Corp Company Profile

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient’s heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Compare EW to Peers and Sector

Metrics to compare
EW
Peers
Sector
Relationship
P/E Ratio
26.7x−6.5x−0.6x
PEG Ratio
3.46−0.180.00
Price/Book
5.5x3.7x2.6x
Price / LTM Sales
6.6x2.7x3.2x
Upside (Analyst Target)
10.1%15.7%44.2%
Fair Value Upside
Unlock−14.6%7.9%Unlock

People Also Watch

75.63
IPGP
+2.05%
31.47
TDC
+0.96%
188.38
BIIB
-0.11%
96.10
EL
+1.22%
69.21
DXCM
-0.50%

FAQ

What Is the Edwards Lifesciences (EW) Stock Price Today?

The Edwards Lifesciences (EW) stock price today is 68.13. Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy. . The dividend yield is

What Stock Exchange Does Edwards Lifesciences Trade On?

Edwards Lifesciences is listed and trades on the NYSE stock exchange.

What Is the Stock Symbol for Edwards Lifesciences?

The stock symbol for Edwards Lifesciences is "EW."

What Is the Edwards Lifesciences Market Cap?

As of today, Edwards Lifesciences market cap is 41.04B.

What is Edwards Lifesciences Earnings Per Share?

The Edwards Lifesciences EPS is 2.44.

What Is the Next Edwards Lifesciences Earnings Date?

Edwards Lifesciences will release its next earnings report on 23 Oct 2024.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.